Interaction between Shiga Toxin and Monoclonal Antibodies: Binding Characteristics and in Vitro Neutralizing Abilities

Antibiotic Treatment of Escherichia coli O157 Infection and the Risk of Hemolytic Uremic Syndrome, Minnesota

(2011) Kirk E. Smith et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Impact of the Nature and Size of the Polymeric Backbone on the Ability of Heterobifunctional Ligands to Mediate Shiga Toxin and Serum Amyloid P Component Ternary Complex Formation

(2011) Pavel I. Kitov et al.   Toxins

Shiga Toxin–Producing Escherichia coli (STEC)

(2010) John M. Hunt   CLINICS IN LABORATORY MEDICINE

Monoclonal antibodies against Stx1B subunit of Escherichia coli O157:H7 distinguish the bacterium from other bacteria

(2010) G. Li et al.   LETTERS IN APPLIED MICROBIOLOGY

Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction

(2010) Carla Zoja et al.   PEDIATRIC NEPHROLOGY

Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7

(2010) Krystle L. Mohawk et al.   VACCINE

Safety and Pharmacokinetics of Urtoxazumab, a Humanized Monoclonal Antibody, against Shiga-Like Toxin 2 in Healthy Adults and in Pediatric Patients Infected with Shiga-Like Toxin-Producing Escherichia coli

(2009) E. L. Lopez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Identification of enteropathogenic and enterohaemorrhagicEscherichia colistrains by immunoserological detection of intimin

(2009) M.A. Menezes et al.   JOURNAL OF APPLIED MICROBIOLOGY

Production and characterization of rabbit polyclonal sera against Shiga toxins Stx1 and Stx2 for detection of Shiga toxin-producingEscherichia coli

(2008) Meire R. B. Mendes-Ledesma et al.   MICROBIOLOGY AND IMMUNOLOGY

Characterization of Monoclonal Immunoglobulin A and G Against Shiga Toxin Binding Subunits Produced by Intranasal Immunization

(2008) T. Tanikawa et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY